India’s benchmark indices, the Nifty 50 and the Sensex, climbed to fresh all-time highs on Thursday. The rally was supported by improving earnings expectations, better valuations, and steady economic conditions backed by supportive fiscal and monetary measures.
The Nifty touched 26,306.95, up 0.39%, while the Sensex advanced 0.49% to 86,026.18, marking a new peak after 14 months.
Take Solutions remained in focus after its share price surged to a fresh 52-week high on Wednesday, marking an impressive 200% gain over the past three months. The stock had also recorded a 52-week high on Tuesday, showing strong upward momentum. Along with the new peak, the share price has now reached its highest level in 21 months.
On Thursday, Take Solutions was trading at Rs 31.30 per share, up 1.36%.
Take Solutions is a healthcare-focused company, engaged in technology-led services for the Life Sciences and Supply Chain Management sectors, including clinical research support, generics assistance, regulatory submissions, and pharmacovigilance.
The company declared its quarterly numbers on October 27, 2025. Take Solutions posted no operating revenue for Q2 FY26, similar to Q2 FY25, while Q1 FY26 had reported a small ₹0.04 crore revenue figure, indicating muted operational activity in the latest quarter.
Despite the absence of operational revenue, the company recorded a consolidated net profit of ₹6.29 crore in Q2 FY26, a reversal from the ₹1.58 crore loss reported a year earlier. The bottom line also improved sequentially, moving from a ₹0.91 crore loss in Q1 FY26 to a profit in the September quarter.
The profit for the quarter was largely attributed to gains from discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (EAL).
Take Solutions Limited announced a major change in its Promoter group shareholding on November 10, 2025, regarding the off-market transaction involving its Promoter group entity, Esyspro Infotech Limited.
According to the disclosure dated November 8, 2025, Esyspro Infotech Limited sold its entire stake in Take Solutions Limited in an off-market sale executed on November 6, 2025. The Promoter group member disposed of 75,40,998 equity shares, valued at ₹52,78,698, excluding any taxes, brokerage, or additional charges.
The transaction has resulted in Esyspro Infotech’s complete exit from the company’s shareholding. Prior to the sale, it held 5.10%, amounting to 7,540,998 shares. Following the disposal, its holding stands at zero shares, marking a full divestment.
Founded in 2000 and based in Chennai, Take Solutions Limited operates as a global technology firm specializing in Life Sciences and Supply Chain Management. The company combines industry expertise with technology solutions to deliver services across clinical, regulatory, safety, and supply chain functions.
Historically, its Life Sciences operations covered full-service CRO activities—clinical trials, BA/BE studies, regulatory filings, and pharmacovigilance—while its supply chain segment focused on engineering support, collaboration tools, process automation, and product re-engineering through proprietary platforms.
The company caters to pharmaceutical, biotech, medical device, and generics manufacturers across India, the US, Europe, and other global markets, supported by delivery centers and domain-rich capabilities.
Take Solutions Limited, with a market cap of ₹467 crore, jumped by 1.36% on Thursday. The stock touched its 52-week high on Wednesday. The stock price has hit a back-to-back 52-week high over the last 3 trading sessions.
In the last 3 months, the stock price of Take Solutions has given multibagger returns of 200%. Over the past year and six months, the company has produced returns of 82% and 259%, respectively.
For android only